Pancreatic Cancer Research

ResearcherIndiana University IndianapolisActive in the last 2 years

Tao Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0013-4987; OpenAlex author ID A5100702268; NIH RePORTER profile ID 11377376. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 grant

Papers 2

  1. Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer. Last author DOI 10.3390/cancers15194742↗
  2. Critical role of NF-κB in pancreatic cancer. Last author DOI 10.18632/oncotarget.2624↗

Grants 1

  1. Improving the potency of novel PRMT5 inhibitor with nanocrystal technology to treat pancreatic cancer R03CA283225↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoon Yeo · 1 shared grant, 2026 · strength 1.26
  2. Ahmad R. Safa · 1 shared paper, 2023 · strength 0.18
  3. Yunlong Liu · 1 shared paper, 2023 · strength 0.18
  4. Aishat Motolani · 1 shared paper, 2023 · strength 0.18
  5. Xiumei Huang · 1 shared paper, 2023 · strength 0.18
  6. Patrick Joseph Loehrer · 1 shared paper, 2014 · strength 0.06
  7. Lakshmi Prabhu · 1 shared paper, 2014 · strength 0.06
  8. Murray Korc · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.